ACAR SEC-arkiveringar - Activecare Inc.- Årsredovisning, Fullmaktsutlåtande, prospekt

Grundläggande statistik

CIK

1429896

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Activecare Inc.

SEC Filings (Chronological Order)

Denna sida innehåller en komplett, kronologisk lista över SEC-arkiveringar, exklusive ägande-arkiveringar som vi tillhandahåller på andra ställen.

July 17, 2018	EX-10.1	See pdf attached. Exhibit 10.1 See pdf attached.
July 17, 2018	EX-10.1	+8JR]6CV\TWJU7Y>C=9S",F5=N( MQ,9-[5WE5/Y2IYPJ,I+,I7)(UW4UA0=I!)[GVR21IG%F#>3M\'HA(5DQ)N_ MLOJ75H^SZOF7T4D2\L/ZR&(884F4.0U[<2\9'>;L "ZM.N-WX'XP(B1,P+]L M),-8_27&6:EZ09IWF'H006.UP6410EUF79@%UAU1"33CCKZ,@U.W\,%^N[\ MYXL@?N%51YY?#Y03?=7%:932'?G)Z(2&X[. begin 644 exh101.pdf M)5!$1BTQ+C<-"B6AL\77#0HQ(# @;V)J#0H\/"]086=E41O8U1I=&QE M('1R=64^/CX^#0IE;F1O8FH-"C(@,"!O8FH-"CP\+T-O=6YT(#4R+TMI9'-; M(#0@,"!2(" R," P(%(@(#8P(# @4B @,3 V(# @4B @,3(V(# @4B @,3,U M(# @4B @,3,W(# @4B @,30U(# @4B @,30Y(# @4B @,34R(# @4B @,38P M(# @4B @,3'1'4W1A=&4\/"]'4S<@-B P M(%(@+T=3." W(# @4B ^/B]&;VYT/#PO1C$@." P(%(@+T8R(#$Q(# @4B O M1C,@,30@,"!2("]&-" Q-R P(%(@/CXO4')O8U
July 17, 2018	8-K/A	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Bankruptcy or Receivership UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 15, 2018 ACTIVECARE, INC. (Exact name of registrant as specified in its charter) Delaware 000-53570 87-0578125 (State or other jurisdiction of incorporation) (Commission File N
July 17, 2018	EX-10.1	+8JR]6CV\TWJU7Y>C=9S",F5=N( MQ,9-[5WE5/Y2IYPJ,I+,I7)(UW4UA0=I!)[GVR21IG%F#>3M\'HA(5DQ)N_ MLOJ75H^SZOF7T4D2\L/ZR&(884F4.0U[<2\9'>;L "ZM.N-WX'XP(B1,P+]L M),-8_27&6:EZ09IWF'H006.UP6410EUF79@%UAU1"33CCKZ,@U.W\,%^N[\ MYXL@?N%51YY?#Y03?=7%:932'?G)Z(2&X[. begin 644 exh101.pdf M)5!$1BTQ+C<-"B6AL\77#0HQ(# @;V)J#0H\/"]086=E41O8U1I=&QE M('1R=64^/CX^#0IE;F1O8FH-"C(@,"!O8FH-"CP\+T-O=6YT(#4R+TMI9'-; M(#0@,"!2(" R," P(%(@(#8P(# @4B @,3 V(# @4B @,3(V(# @4B @,3,U M(# @4B @,3,W(# @4B @,30U(# @4B @,30Y(# @4B @,34R(# @4B @,38P M(# @4B @,3'1'4W1A=&4\/"]'4S<@-B P M(%(@+T=3." W(# @4B ^/B]&;VYT/#PO1C$@." P(%(@+T8R(#$Q(# @4B O M1C,@,30@,"!2("]&-" Q-R P(%(@/CXO4')O8U
July 17, 2018	EX-10.1	See pdf attached. Exhibit 10.1 See pdf attached.
July 17, 2018	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Bankruptcy or Receivership UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 17, 2018 ACTIVECARE, INC. (Exact name of registrant as specified in its charter) Delaware 000-53570 87-0578125 (State or other jurisdiction of incorporation) (Commission File Num
March 30, 2018	8-K	Termination of a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 20, 2018 ACTIVECARE, INC. (Exact name of registrant as specified in its charter) Delaware 000-53570 87-0578125 (State or other jurisdiction of incorporation) (Commission File Num
February 15, 2018	SC 13G/A	ACAR / Activecare Inc. / KEENER JUSTIN - SC 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Information to be included in Statements filed pursuant to Rule 13d-1(b), (c) AND (d) (AMENDMENT NO. 1) activecare, inc. (Name of Issuer) COMMON Stock, $0.00001 par value (Title of Class of Securities) 005057302 (CUSIP Number) December 31, 2017 (Date of event which requires filing of this Statement) Check the appropriate box to
January 31, 2018	EX-10.1	EMPLOYMENT AGREEMENT Exhibit 10.1 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the "Agreement") is effective as of the 5th day of September, 2017, between Jeffrey Peterson, an individual ("Executive"), and ACTIVECARE, INC., a Delaware corporation ("ActiveCare"). Executive and ActiveCare are sometimes collectively referred to herein as the "parties." RECITALS WHEREAS, ActiveCare is a corporation engaged in the busin
January 31, 2018	10-Q	ACAR / Activecare Inc. 10Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2017 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-53570 ACTIVECARE, INC. (Exact
December 28, 2017	8-K	Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 22, 2017 ACTIVECARE, INC. (Exact name of registrant as specified in its charter) Delaware 000-53570 87-0578125 (State or other jurisdiction of incorporation) (Commission File
December 14, 2017	EX-17.3	Letter of resignation from Eric Robinson EX-17.3 9 f8k120617ex17-3activecare.htm LETTER OF RESIGNATION FROM ERIC ROBINSON Exhibit 17.3 December 11, 2017 To the Members of the Board of Directors of ActiveCare, Inc. I have not been employed or engaged in any way (officer, employee, consultant, etc.) by ActiveCare, Inc. (the “Company”) since June 1, 2017. To the extent this has not already occurred, this letter shall serve as formal notice
December 14, 2017	EX-10.1	Form of Forbearance and Lock Up Agreement Exhibit 10.1 LOCK-UP & FORBEARANCE LETTER AGREEMENT The undersigned understands that ActiveCare, Inc., a Delaware corporation (the ?Company?) is raising up to $1,500,000 in a convertible debt security with certain terms and conditions. As such, the undersigned hereby irrevocably agrees to the terms and conditions set forth in this letter agreement relating to a lock-up of common share disposition
December 14, 2017	EX-17.1	Letter of resignation from Bradley Robinson Exhibit 17.1 December 11, 2017 To the Members of the Board of Directors of ActiveCare, Inc. This letter shall serve as formal notice of my resignation, effective immediately, from my position as a member of the board of directors of ActiveCare, Inc. (the ?Company?), and all other positions with the Company to which I have been assigned, regardless of whether I served in such capacity. The resignat
December 14, 2017	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits 8-K 1 f8k120617activecareinc.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 6, 2017 ACTIVECARE, INC. (Exact name of registrant as specified in its charter) Delaware 000-53570 87-0578125 (State or other j
December 14, 2017	EX-4.1	Form of Warrant EX-4.1 2 f8k120617ex4-1activecare.htm FORM OF WARRANT Exhibit 4.1 THIS WARRANT AND THE SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT OR APPLICABLE EX
December 14, 2017	EX-17.2	Letter of resignation from Robert J. Welgos Exhibit 17.2 December 11, 2017 To the Members of the Board of Directors of ActiveCare, Inc. This letter shall serve as formal notice of my resignation, effective immediately, from my position as a member of the board of directors of ActiveCare, Inc. (the ?Company?), and all other positions with the Company to which I have been assigned, regardless of whether I served in such capacity. The resignat
December 14, 2017	EX-17.4	Letter of resignation from Jeffrey S. Peterson Exhibit 17.4 December 11, 2017 To the Members of the Board of Directors of ActiveCare, Inc. This letter shall serve as formal notice of my resignation, effective immediately, from my position as Executive Chairman of the Board of ActiveCare, Inc. (the ?Company?) while acknowledging that I will continue to serve the Company as a director and Executive Vice President. The resignation is not the resu
December 14, 2017	EX-10.2	Form of Securities Purchase Agreement Exhibit 10.2 SECURITIES PURCHASE AGREEMENT DOCUMENT SPA-12072017 This Securities Purchase Agreement (this ?Agreement?) is dated as of December , 2017, between ActiveCare, Inc., a Delaware corporation (the ?Issuer?) and (the ?Investor?) (referred to collectively herein as the ?Parties?). WHEREAS, the Issuer intends to conduct a private placement of its securities to raise net proceeds to the Issuer
December 14, 2017	EX-10.3	Form of Promissory Note EX-10.3 5 f8k120617ex10-3activecare.htm FORM OF PROMISSORY NOTE Exhibit 10.3 ACAR CONVERTIBLE NOTE FOR VALUE RECEIVED, ActiveCare, Inc., a Delaware corporation (the “Issuer” of this Security) with at least 239,000,000 common shares issued and outstanding, issues this Security and promises to pay to ., a Cayman Islands company, or its Assignees (the “Investor”) the Principal Sum along with the Inte
December 14, 2017	EX-10.4	Employment Agreement by and Between Mark J. Rosenblum and ActiveCare, Inc. (incorporated by reference to Current Report on Form 8-K filed with the SEC on December 14, 2017). Exhibit 10.4 EMPLOYMENT AGREEMENT This Employment Agreement (the ?Agreement?) is effective as of December 7, 2017, by and between ACTIVECARE, INC., a Delaware corporation (the ?Company?), and Mark J. Rosenblum (the ?Executive?). WHEREAS, the Company and Executive desire to enter into this Agreement pursuant to which the Company will employ Executive in the capacity of Chief Executive Officer, for
October 16, 2017	RW	Activecare FORM RW ActiveCare, Inc. 1365 West Business Park Drive Orem, UT 84058 October 16, 2017 VIA EDGAR Larry Spirgel, Assistant Director Office of Telecommunications Mail Stop 3030 Division of Corporation Finance Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549 Re: ActiveCare, Inc. (the "Company") Registration Statement on Form S-1 (File No. 333-212589) Ladies and Gentlemen: Pursuant
August 14, 2017	NT 10-Q	Activecare ACTIVECARE 12B25 10Q 2017-06-30 acar12b-25.htm UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Expires: August 31, 2018 Washington, D.C. 20549 Estimated average burden Hours per response 2.50 FORM 12b-25 SEC FILE NUMBER 0-53570 NOTIFICATION OF LATE FILING CUSIP NUMBER (Check One): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: June 30, 2
May 19, 2017	10-Q	Activecare 10Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2017 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-53570 ACTIVECARE, INC. (Exact
May 15, 2017	NT 10-Q	Activecare ACTIVECARE 12B25 10Q 2017-03-31 acar12b-25.htm UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Expires: August 31, 2018 Washington, D.C. 20549 Estimated average burden Hours per response 2.50 FORM 12b-25 SEC FILE NUMBER 0-53570 NOTIFICATION OF LATE FILING CUSIP NUMBER (Check One): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: March 31,
April 20, 2017	EX-10.2	Joint Venture Agreement by and between Colorado Choice Health Plans and ActiveCare, Inc. (incorporated by reference to Current Report on Form 8-K filed with the SEC on April 20, 2017). Exhibit 10.2 Joint Venture Agreement THIS JOINT VENTURE AGREEMENT ("Agreement") is entered into effective this 31 S` day of March, 2017 by and between ActiveCare, Inc, a Delaware corporation and Colorado Choice Health Plans, a Colorado non-profit corporation ("CCHP"). RECITALS A. CCHP has nurses who have expertise in disease management especially as it relates to the chronic illness of diabetes ("
April 20, 2017	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 17, 2017 ACTIVECARE, INC. (Exact name of registrant as specified in its charter) Delaware 000-53570 87-0578125 (State or other jurisdiction of incorporation) (Commission File Nu
April 20, 2017	EX-10.3	Amendment # 5 to the Securities Purchase Agreement and the $2,000,000 Promissory Note dated September 19, 2016 (incorporated by reference to Current Report on Form 8-K filed with the SEC on April 20, 2017). Exhibit 10.3 AMENDMENT #5 TO THE SECURITIES PURCHASE AGREEMENT AND TO THE $2,000,000 PROMISSORY NOTE This Amendment #5, dated April 19, 2017 (this "Amendment"), is by and between ActiveCare, Inc., a Delaware corporation (the "Issuer") and JMJ Financial (the "Investor") (referred to collectively herein as the "Parties") WHEREAS, the Issuer and the Investor entered into a Securities Purchase Agreeme
April 20, 2017	EX-10.1	Factoring Agreement by and between Complete Business Solutions Group, Inc. and ActiveCare, Inc. (incorporated by reference to Current Report on Form 8-K filed with the SEC on April 20, 2017). Exhibit 10.1 141 N. 2 nd Street Philadelphia, Pennsylvania 19106 Phone: 215-922-2636 Fax: 888-803-4886 FACTORING AGREEMENT Dated the 17 th day of April, 2017, by and between Complete Business Solutions Group, Inc. ("CBSG" and/or "PURCHASER") and the "SELLER/MERCHANT" listed below (as "Seller/Merchant" or "the Merchant "). Business Legal Name: ACTIVECARE, INC D/B/A: VOLU-SOL, REAL TIME HEALTH, GWIR
April 3, 2017	S-1/A	As filed with the Securities and Exchange Commission on April 3, 2017 As filed with the Securities and Exchange Commission on April 3, 2017 Registration No.
April 3, 2017	EX-10.51	*REMAINDER OF PAGE INTENTIONALLY LEFT BLANK* Exhibit 10.51 April 3, 2017 Telcare Medical Supply, LLC. 150 Baker Avenue, Ext #300 Concord MA 01742 VIA ELECTRONIC MAIL Re: Agreement to Convert ? Promissory Note Gentlemen/Ladies: You are being sent this letter as you are currently the holder of an Amended and Restated Non-Negotiable Promissory Note dated February 28, 2017 (the ?Note?) issued by ActiveCare, Inc. (the ?Company?) in the original p
April 3, 2017	EX-3.22	ACTIVECARE, inc. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS SERIES H CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE delaware GENERAL CORPORATION LAW Exhibit 3.22 ACTIVECARE, inc. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES H CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE delaware GENERAL CORPORATION LAW The undersigned, does hereby certify that: 1. He is the Chief Executive Officer of ActiveCare, Inc., a Delaware corporation (the “Corporation”). 2. The Corporation is authorized to issue 10,000,0000 s
April 3, 2017	EX-1.1	UNDERWRITING AGREEMENT ACTIVECARE, INC. JOSEPH GUNNAR & CO., LLC as Representative of the Several Underwriters ACTIVECARE, INC. UNDERWRITING AGREEMENT Exhibit 1.1 UNDERWRITING AGREEMENT between ACTIVECARE, INC. and JOSEPH GUNNAR & CO., LLC as Representative of the Several Underwriters ACTIVECARE, INC. UNDERWRITING AGREEMENT New York, New York April [●], 2017 Joseph Gunnar & Co., LLC As Representative of the several Underwriters named on Schedule 1 attached hereto 30 Broad Street, 11th Fl New York, NY 10004 Ladies and Gentlemen: The undersigned,
March 30, 2017	EX-10.1	LOAN AGREEMENT EX-10.1 2 exh101.htm LOAN AGREEMENT Exhibit 10.1 LOAN AGREEMENT THIS LOAN AGREEEMENT (the "Agreement") is made and entered into as of the 21 day of March 2017, by and between ActiveCare, Inc., a Delaware corporation having an address at 1365 West Business Park Drive, Suite 100, Orem, Utah 84058 (the "Borrower"), and Jeff Greene, having an address at 135 Stanley Farm Road, Kernersville, North Carol
March 30, 2017	8-K/A	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K /A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 21, 2017 ACTIVECARE, INC. (Exact name of registrant as specified in its charter) Delaware 000-53570 87-0578125 (State or other jurisdiction of incorporation) (Commission File
March 28, 2017	S-1/A	As filed with the Securities and Exchange Commission on March 28, 2017 As filed with the Securities and Exchange Commission on March 28, 2017 Registration No.
March 23, 2017	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 20, 2017 ACTIVECARE, INC. (Exact name of registrant as specified in its charter) Delaware 000-53570 87-0578125 (State or other jurisdiction of incorporation) (Commission File Nu
March 23, 2017	EX-10.1	MODIFICATION NO. 1 TO LOAN AND SECURITY AGREEMENT EX-10.1 2 exhibit10-1.htm MODIFICATION NO.1 TO LOAN AND SECURITY AGREEMENT Exhibit 10.1 MODIFICATION NO. 1 TO LOAN AND SECURITY AGREEMENT This Modification No. 1 to Loan and Security Agreement (this "Modification") is entered into as of March 17, 2017 (such date, the "Modification Date") by and between Partners for Growth IV, L.P., a Delaware limited partnership with its principal place of busines
March 23, 2017	EX-10.1	LOAN AGREEMENT Exhibit 10.1 LOAN AGREEMENT THIS LOAN AGREEEMENT (the "Agreement") is made and entered into as of the 21 day of March 2017, by and between ActiveCare, Inc., a Delaware corporation having an address at 1365 West Business Park Drive, Suite 100, Orem, Utah 84058 (the "Borrower"), and Jeff Greene, having an address at 135 Stanley Farm Road, Kernersville, North Carolina 28645 (the "Lender"). WHEREAS, t
March 23, 2017	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 21, 2017 ACTIVECARE, INC. (Exact name of registrant as specified in its charter) Delaware 000-53570 87-0578125 (State or other jurisdiction of incorporation) (Commission File Nu
March 13, 2017	S-1/A	As filed with the Securities and Exchange Commission on March 13, 2017 As filed with the Securities and Exchange Commission on March 13, 2017 Registration No.
March 10, 2017	S-1/A	As filed with the Securities and Exchange Commission on March 10, 2017 As filed with the Securities and Exchange Commission on March 10, 2017 Registration No.
March 10, 2017	EX-10.44	FORBEARANCE EXTENSION UNDER LOAN AND SECURITY AGREEMENT Exhibit 10.44 FORBEARANCE EXTENSION UNDER LOAN AND SECURITY AGREEMENT This agreement (the ?Forbearance Extension?) is entered into as of December 31, 2016 (such date, the ?Forbearance Extension Effective Date?) and is, inter alia, an extension of PFG?s forbearance under that certain Forbearance under Loan and Security Agreement dated November 1, 2016 (the ?Expiring Forbearance? and such date, the
March 9, 2017	EX-10.1	AMENDMENT #3 TO THE SECURITIES PURCHASE AGREEMENT AND TO THE $1,5000,000 PROMISSORY NOTE EX-10.1 3 exh101.htm AMENDMENT #3 TO THE SECURITIES PURCHASE AGREEMENT AND TO THE $1,500,000 PROMISSORY NOTE Exhibit 10.1 AMENDMENT #3 TO THE SECURITIES PURCHASE AGREEMENT AND TO THE $1,5000,000 PROMISSORY NOTE This Amendment No. 3, dated March 1, 2017 (this "Amendment"), is by and between ActiveCare, Inc., a Delaware corporation (the "Issuer") and JMJ Financial (the "Investor") (referred to colle
March 9, 2017	EX-4.1	COMMON STOCK PURCHASE WARRANT DOCUMENT W-03032017 ACTIVECARE, INC. Exhibit 4.1 THIS WARRANT AND THE SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT OR APPLICABLE EXEMPTION OR SAFE HARBOR PROVISION. COMMON STOCK PURCHAS
March 9, 2017	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 8-K 1 activecare.htm 8K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 3, 2017 ACTIVECARE, INC. (Exact name of registrant as specified in its charter) Delaware 000-53570 87-0578125 (State or other jurisdiction of incorporati
March 2, 2017	EX-4.1	COMMON STOCK PURCHASE WARRANT Activecare, inc. Exhibit 4.1 COMMON STOCK PURCHASE WARRANT Activecare, inc. Warrant Shares: Initial Exercise Date: [?] , [?] Issue Date: [?] , 2016 CUSIP: ISIN: THIS COMMON STOCK PURCHASE WARRANT (the ?Warrant?) certifies that, for value received, or its assigns (the ?Holder?) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [?
March 2, 2017	S-1/A	As filed with the Securities and Exchange Commission on March 1, 2017 As filed with the Securities and Exchange Commission on March 1, 2017 Registration No.
March 2, 2017	EX-10.45	WARRANT AGENT AGREEMENT Exhibit 10.45 WARRANT AGENT AGREEMENT WARRANT AGENT AGREEMENT (this ?Warrant Agreement?) dated as of , 2017 (the ?Issuance Date?) between [COMPANY], a company incorporated under the laws of the State of [STATE] (the ?Company?), and Securities Transfer Corporation (the ?Warrant Agent?). WHEREAS, pursuant to the terms of that certain Underwriting Agreement (?Underwriting Agreement?), dated , 2017, b
March 2, 2017	EX-10.47	SERIES G LOCK-UP AGREEMENT Exhibit 10.47 SERIES G LOCK-UP AGREEMENT This AMENDED LOCK-UP AGREEMENT (the ?Amended Series G Lock-Up Agreement?) is made and entered into as of , 2017, by and between ActiveCare, Inc. (the ?Company?) and the undersigned Series G Convertible Preferred Stock holder, (the ?Holder?). For all purposes of this Amended Series G Lock-Up Agreement, ?Holder? includes any affiliate or controlling person of
March 2, 2017	EX-4.2	THIS PURCHASE WARRANT IS NOT EXERCISABLE PRIOR TO ________, 2017. VOID AFTER 5:00 P.M., EASTERN TIME, ____________, 2021. WARRANT TO PURCHASE COMMON STOCK Activecare, inc. Exhibit 4.2 THE REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT FOR A PERIOD OF ONE HUNDRED EIGHTY DAYS FOLLOWING THE EFFECTIVE DATE (DEFIN
February 21, 2017	EX-10.4	AMENDMENT OF FORBEARANCE EXTENSION UNDER LOAN AND SECURITY AGREEMENT Exhibit 10.4 AMENDMENT OF FORBEARANCE EXTENSION UNDER LOAN AND SECURITY AGREEMENT This Amendment of Forbearance Extension under Loan and Security Agreement (this "Forbearance Amendment") is entered into as of February 15, 2017 (such date, the "Forbearance Amendment Effective Date") by and between Partners for Growth IV, L.P., a Delaware limited partnership with its principal place of business at 1
February 21, 2017	EX-10.3	Form of Amendment to Letter Agreement Regarding Conversion and Lock Up Letter for Others Exhibit 10.3 Form of Amendment to Letter Agreement Regarding Conversion and Lock Up Letter for Others February , 2017 VIA ELECTRONIC MAIL Re: Amendment to Letter Agreement regarding Conversion and Lock up Letter Dear : Reference is made to that certain letter agreement pursuant to which you agreed to convert your into restricted shares of Common Stock (the "Conversion Letter Agreement") and certai
February 21, 2017	EX-10.2	Form of Amendment to Letter Agreement Regarding Conversion and Lock Up Letter for Series F Exhibit 10.2 Form of Amendment to Letter Agreement Regarding Conversion and Lock Up Letter for Series F February , 2017 VIA ELECTRONIC MAIL Re: Amendment to Letter Agreement regarding Conversion and Lock up Letter Dear : Reference is made to that certain letter agreement pursuant to which you agreed to (i) convert your Total Debenture Obligation into restricted shares of Common Stock and Warrants
February 21, 2017	EX-10.1	Form of Lock-Up Letter Agreement EX-10.1 2 exh101.htm FORM OF LOCK-UP LETTER AGREEMENT Exhibit 10.1 Form of Lock-Up Letter Agreement Joseph Gunnar & Co., LLC 30 Broad Street, 11th FL New York, NY 10004 As Representative of the several Underwriters named on Schedule 1 to the Underwriting Agreement referenced below Ladies and Gentlemen: The undersigned understands that you and certain other firms (the "Underwriters") propose to ent
February 21, 2017	10-Q	Activecare 10Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: December 31, 2016 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-53570 ACTIVECARE, INC. (Ex
February 14, 2017	NT 10-Q	Activecare ACTIVECARE 12B25 10Q 2016-12-31 acar12b-25.htm UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Expires: August 31, 2018 Washington, D.C. 20549 Estimated average burden Hours per response 2.50 FORM 12b-25 SEC FILE NUMBER 0-53570 NOTIFICATION OF LATE FILING CUSIP NUMBER (Check One): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: December 3
February 10, 2017	SC 13D	ACAR / Activecare Inc. / DALTON JAMES - SCHEDULE 13D Activist Investment SC 13D 1 schedule13d.htm SCHEDULE 13D SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. ) Activecare, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 0001429896 (CUSIP Number) Jim Dalton PO Box 3621 Park City, Utah 84060 Tel. (801) 231-6648 (Name, Address and Telephone Number of Person Authorized to Rec
February 3, 2017	EX-3.1	CERTIFICATE OF DESIGNATIONS, PREFERENCES AND RIGHTS OF SERIES G CONVERTIBLE PREFERRED STOCK, $0.00001 PAR VALUE PER SHARE Exhibit 3.1 CERTIFICATE OF DESIGNATIONS, PREFERENCES AND RIGHTS OF SERIES G CONVERTIBLE PREFERRED STOCK, $0.00001 PAR VALUE PER SHARE ActiveCare, Inc., a corporation organized and existing under the laws of the State of Delaware (the ?Company?), hereby certifies that the following resolution was adopted by the Board of Directors of the Company (the ?Board?) on November 1, 2016, in accordance with
February 3, 2017	EX-10.1	AMENDMENT #2 TO THE SECURITIES PURCHASE AGREEMENT AND TO THE $1,5000,000 PROMISSORY NOTE EX-10.1 3 f8k013017ex10iactivecare.htm AMENDMENT #2 TO SECURITIES PURCHASE AGREEMENT AND PROMISSORY NOTE Exhibit 10.1 AMENDMENT #2 TO THE SECURITIES PURCHASE AGREEMENT AND TO THE $1,5000,000 PROMISSORY NOTE This Amendment No. 2, dated January 30, 2017 (this "Amendment"), is by and between ActiveCare, Inc., a Delaware corporation (the "Issuer") and JMJ Financial (the "Investor") (referred to collec
February 3, 2017	EX-10.3	LOCK-UP AGREEMENT Exhibit 10.3 LOCK-UP AGREEMENT This LOCK-UP AGREEMENT (this ?Agreement?) is made and entered into as of , 2017, by and between ActiveCare, Inc. (the ?Company?) and the undersigned Series G Convertible Preferred Stock holder, (the ?Holder?). For all purposes of this Agreement, ?Holder? includes any affiliate or controlling person of Shareholder, and any other agent, representative or other person w
February 3, 2017	EX-10.2	Waiver and Clarification Exhibit 10.2 Waiver and Clarification JMJ hereby waives all negative covenants in any and all agreements (warrant, note, etc.) in relation to the time of which the reverse stock split was needing to be effectuated by, which is hereby agreed to as January 27, 2017. It is acknowledged that the reverse stock split became effective in the marketplace the morning of January 27, 2017. As such, and by wa
February 3, 2017	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 30, 2017 ACTIVECARE, INC. (Exact name of registrant as specified in its charter) Delaware 000-53570 87-0578125 (State or other jurisdiction of incorporation) (Commission File
February 3, 2017	SC 13D/A	ACAR / Activecare Inc. / PETERSON JEFFREY S - SCHEDULE 13 D/A Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Activecare, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 005057302 (CUSIP Number) Jeff S. Peterson 539 Blackhawk Lane Alpine, Utah 84004 Tel. (801) 259-2595 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communic
February 3, 2017	EX-1.1	UNDERWRITING AGREEMENT ACTIVECARE, INC. JOSEPH GUNNAR & CO., LLC as Representative of the Several Underwriters ACTIVECARE, INC. UNDERWRITING AGREEMENT Exhibit 1.1 UNDERWRITING AGREEMENT between ACTIVECARE, INC. and JOSEPH GUNNAR & CO., LLC as Representative of the Several Underwriters ACTIVECARE, INC. UNDERWRITING AGREEMENT New York, New York [?], 2016 Joseph Gunnar & Co., LLC As Representative of the several Underwriters named on Schedule 1 attached hereto 30 Broad Street, 11th Fl New York, NY 10004 Ladies and Gentlemen: The undersigned, Active
February 3, 2017	EX-10.46	LOCK-UP AGREEMENT Exhibit 10.46 LOCK-UP AGREEMENT This LOCK-UP AGREEMENT (this “Agreement”) is made and entered into as of , 2017, by and between ActiveCare, Inc. (the “Company”) and the undersigned Series G Convertible Preferred Stock holder, (the “Holder”). For all purposes of this Agreement, “Holder” includes any affiliate or controlling person of Shareholder, and any other agent, representative or other person
February 3, 2017	EX-99.1	Consent of Director Nominee Exhibit 99.1 Consent of Director Nominee In accordance with Rule 438 under the Securities Act of 1933, as amended (the ?Securities Act?), the undersigned hereby consents to being named as a director nominee and impending board member of ActiveCare, Inc. (the ?Company?) in the Company?s Registration Statement on Form S-1 (Registration No. 333-212589) and in all amendments (including post-effective
February 3, 2017	EX-99.2	Consent of Director Nominee Exhibit 99.2 Consent of Director Nominee In accordance with Rule 438 under the Securities Act of 1933, as amended (the ?Securities Act?), the undersigned hereby consents to being named as a director nominee and impending board member of ActiveCare, Inc. (the ?Company?) in the Company?s Registration Statement on Form S-1 (Registration No. 333-212589) and in all amendments (including post-effective
February 3, 2017	S-1/A	As filed with the Securities and Exchange Commission on February 2, 2017 S-1/A 1 fs12016a1activecareinc.htm AMENDMENT TO FORM S-1 As filed with the Securities and Exchange Commission on February 2, 2017 Registration No. 333-212589 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No.1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ACTIVECARE, INC. (Exact name of registrant as specified in its charter) Delaware 3669 8
February 3, 2017	EX-3.21	CERTIFICATE OF DESIGNATIONS, PREFERENCES AND RIGHTS OF SERIES G CONVERTIBLE PREFERRED STOCK, $0.00001 PAR VALUE PER SHARE Exhibit 3.21 CERTIFICATE OF DESIGNATIONS, PREFERENCES AND RIGHTS OF SERIES G CONVERTIBLE PREFERRED STOCK, $0.00001 PAR VALUE PER SHARE ActiveCare, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), hereby certifies that the following resolution was adopted by the Board of Directors of the Company (the “Board”) on November 1, 2016, in accordance with
February 1, 2017	SC 13G	ACAR / Activecare Inc. / KEENER JUSTIN - SCHEDULE 13G Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Information to be included in Statements filed pursuant to Rule 13d-1(b), (c) AND (d) activecare, inc. (Name of Issuer) COMMON Stock, $0.00001 par value (Title of Class of Securities) 005057203 (CUSIP Number) September 19, 2016 (Date of event which requires filing of this Statement) Check the appropriate box to designate the ru
January 13, 2017	10-K	Activecare 10K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2016 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d ) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 0-53570 ActiveCare, Inc. (Exact name of registrant as s
January 13, 2017	EX-10.39	1365 West Business Park Drive, Orem UT 84058 P 877-219-6050 I F 855-864-2511 Exhibit 10.39 December 7, 2016 VIA ELECTRONIC MAIL Re: Agreement to Convert – Promissory Note Dear : You are being sent this letter as you are currently the holder of a promissory note dated March 24, 2016 (the "Note") issued by ActiveCare, Inc. (the "Company") pursuant to which you are owed remaining principal of $250,000.00 ("Principal Amount"), along with accrued interest of $15,616.44 through
January 13, 2017	EX-10.34	1365 West Business Park Drive, Orem UT 84058 P 877-219-6050 I F 855-864-2511 Exhibit 10.34 [DATE] [NAME AND ADDRESS OF SERIES F PREFERRED SHAREHOLDER] VIA ELECTRONIC MAIL Re: Agreement to Convert – Debentures Dear : Reference is made to that certain Securities Exchange Agreement, dated February 19, 2016 (the "Securities Exchange Agreement"), entered into by and among ActiveCare Inc. (the "Company") and the holders of the Company's Series F Convertible Preferred Stock (the
January 13, 2017	EX-10.43	1365 West Business Park Drive, Orem UT 84058 P 877-219-6050 I F 855-864-2511 Exhibit 10.43 December 21, 2016 Robert Welgos 9 Ridge Road Wharton, NJ 07885 VIA ELECTRONIC MAIL Re: Agreement to Convert – Series E Preferred Stock Dear Mr. Welgos: You are being sent this letter as a holder of 13,843 shares of Series E Convertible Preferred Stock, par value $.00001 per share ("Series E Preferred Stock") of ActiveCare, Inc. (the "Company"), which are convertible into shares of th
January 13, 2017	EX-10.42	1365 West Business Park Drive, Orem UT 84058 P 877-219-6050 I F 855-864-2511 Exhibit 10.42 December 21, 2016 Tyumen Holdings, LLC Attn: Jeffrey Peterson 539 Blackhawk Ln Alpine, UT 84004 VIA ELECTRONIC MAIL Re: Agreement to Convert – Series D Preferred Stock Dear Mr. Peterson: You are being sent this letter as a holder of 25,000 shares of ActiveCare, Inc.'s (the "Company") Series D Convertible Preferred Stock, par value $.00001 per share (the "Series D Preferred Stock"), w
January 13, 2017	EX-10.38	*REMAINDER OF PAGE INTENTIONALLY LEFT BLANK* 1365 West Business Park Drive, Orem UT 84058 P 877-219-6050 I F 855-864-2511 www.activecare.com Exhibit 10.38 December 21, 2016 VIA ELECTRONIC MAIL Re: Agreement to Convert – Promissory Note Dear : You are being sent this letter as you are currently the holder of a promissory note dated March 24, 2016 (the "Note") issued by ActiveCare, Inc. (the "Company") pursuant to which you are owed remaining principal of $64,260.69 ("Principal Amount"), along with accrued interest of $37,552.59 through
January 13, 2017	EX-10.33	LOCK-UP LETTER AGREEMENT Exhibit 10.33 LOCK-UP LETTER AGREEMENT Joseph Gunnar & Co., LLC 30 Broad Street, 11th FL New York, NY 10004 As Representative of the several Underwriters named on Schedule 1 to the Underwriting Agreement referenced below Ladies and Gentlemen: The undersigned understands that you and certain other firms (the "Underwriters") propose to enter into an Underwriting Agreement (the "Underwriting Agreemen
January 13, 2017	EX-10.36	1365 West Business Park Drive, Orem UT 84058 P 877-219-6050 I F 855-864-2511 Exhibit 10.36 December 21, 2016 Robert Welgos 9 Ridge Road Wharton, NJ 07885 VIA ELECTRONIC MAIL Re: Agreement to Convert – Account Payable Dear Mr. Welgos: You are being sent this letter as you are currently owed the sum of $42,500 (the "Account Payable Amount") from ActiveCare, Inc. (the "Company"). Our Current Financing As you may be aware, the Company is currently in the process of pursuing a
January 13, 2017	EX-10.35	1365 West Business Park Drive, Orem UT 84058 P 877-219-6050 I F 855-864-2511 Exhibit 10.35 December 21, 2016 VIA ELECTRONIC MAIL Re: Agreement to Convert – Account Payable Dear : You are being sent this letter as you are currently owed the sum of $73,667.00 (the "Account Payable Amount") from ActiveCare, Inc. (the "Company"). Our Current Financing As you may be aware, the Company is currently in the process of pursuing a public offering of its securities to raise up to $17
January 13, 2017	EX-10.41	1365 West Business Park Drive, Orem UT 84058 P 877-219-6050 I F 855-864-2511 EX-10.41 11 exh1041.htm FORM OF GG SERIES D PREFERRED STOCK CONVERSION AGREEMENT Exhibit 10.41 December 21, 2016 VIA ELECTRONIC MAIL Re: Agreement to Convert – Series D Preferred Stock Dear : You are being sent this letter as a holder of 20,000 shares of Series D Convertible Preferred Stock, par value $.00001 per share (the "Series D Preferred Stock") of ActiveCare, Inc. (the "Company"), which are
January 13, 2017	EX-10.40	1365 West Business Park Drive, Orem UT 84058 P 877-219-6050 I F 855-864-2511 Exhibit 10.40 December 21, 2016 Bluestone Advisors, LLC Blackhawk Properties, LLC Banyan Investment Company LLC The Mark and Nancy Peterson Foundation Tyumen Holdings, LLC Jeffrey Peterson c/o Jeffrey Peterson 539 Blackhawk Ln Alpine, UT 84004 VIA ELECTRONIC MAIL Re: Agreement to Convert – Debt Obligations Dear Mr. Peterson: You are being sent this letter as ActiveCare, Inc. (the "Company") is cur
January 13, 2017	EX-10.37	1365 West Business Park Drive, Orem UT 84058 P 877-219-6050 I F 855-864-2511 Exhibit 10.37 December 21, 2016 ADP Management Attn: David Derrick 1401 North 1075 West Suite 240 Farmington, UT 84025 VIA ELECTRONIC MAIL Re: Agreement to Convert – Promissory Note Dear Mr. Derrick: You are being sent this letter as you are currently the holder of a promissory note dated February 18, 2016 (the "Note") issued by ActiveCare, Inc. (the "Company") pursuant to which you are owed remai
January 13, 2017	EX-3.20	STATE OF DELAWARE CERTIFICATE OF CORRECTION Exhibit 3.20 STATE OF DELAWARE CERTIFICATE OF CORRECTION ActiveCare, Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware. DOES HEREBY CERTIFY: 1. The name of the corporation is ActiveCare, Inc. 2. A Certificate of Amendment to the Certificate of Incorporation was filed on November 1, 2016 with the Secretary of State of Delaware and
December 29, 2016	NT 10-K	Activecare ACTIVECARE 12B25 10Q 2016-06-30 acar12b-25.htm UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Expires: August 31, 2018 Washington, D.C. 20549 Estimated average burden Hours per response 2.50 FORM 12b-25 SEC FILE NUMBER 0-53570 NOTIFICATION OF LATE FILING CUSIP NUMBER (Check One): x Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: September
November 16, 2016	EX-10.1	FORBEARANCE AND CONSENT UNDER LOAN AND SECURITY AGREEMENT Exhibit 10.1 FORBEARANCE AND CONSENT UNDER LOAN AND SECURITY AGREEMENT This Forbearance under Loan and Security Agreement (this " Forbearance") is entered into as of November 1, 2016 (the " Forbearance Effective Date"), by and between Partners for Growth IV, L.P., a Delaware limited partnership with its principal place of business at 1660 Tiburon Blvd., Suite D, Tiburon California 94920 (" PFG") a
November 16, 2016	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 10, 2016 ACTIVECARE, INC. (Exact name of registrant as specified in its charter) Delaware 000-53570 87-0578125 (State or other jurisdiction of incorporation) (Commission File
November 8, 2016	EX-3.1	CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION ACTIVECARE, INC. Pursuant to and in accordance with Section 242 of the General Corporation Law of the State of Delaware, as amended (the "DGCL"), the undersigned, ActiveCare, Inc. (the "Cor Exhibit 3.1 CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION OF ACTIVECARE, INC. Pursuant to and in accordance with Section 242 of the General Corporation Law of the State of Delaware, as amended (the "DGCL"), the undersigned, ActiveCare, Inc. (the "Corporation") hereby declares and certifies as follows: 1. The name of the Corporation is ActiveCare, Inc. 2. The Certificate of Incorpora
November 8, 2016	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2016 ACTIVECARE, INC. (Exact name of registrant as specified in its charter) Delaware 000-53570 87-0578125 (State or other jurisdiction of incorporation) (Commission File
November 7, 2016	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2016 ACTIVECARE, INC. (Exact name of registrant as specified in its charter) Delaware 000-53570 87-0578125 (State or other jurisdiction of incorporation) (Commission File
November 7, 2016	EX-10.3	ACTIVECARE, INC. NON-QUALIFIED STOCK OPTION AGREEMENT Exhibit 10.3 ACTIVECARE, INC. NON-QUALIFIED STOCK OPTION AGREEMENT NON-EMPLOYEE THIS STOCK OPTION AGREEMENT (the " Agreement") entered into as of the day of 20 by and between ActiveCare, Inc. (the " Company") and (the " Optionee"). WHEREAS, pursuant to the authority of the Board of Directors (the " Board"), the Company has granted the Optionee the right to purchase common stock, $0.00001 par value
November 7, 2016	EX-10.2	ACTIVECARE, INC. RESTRICTED STOCK AGREEMENT Exhibit 10.2 ACTIVECARE, INC. RESTRICTED STOCK AGREEMENT THIS RESTRICTED STOCK AGREEMENT (the "Agreement") is made and entered into as of the day of , 20 (the "Effective Date") by and between ActiveCare, Inc., a Delaware corporation (the "Company"), having an address at 1365 West Business Park Drive, Orem, UT 84058 and ("Grantee"), having an address at . 1. Grant of Restricted Shares. Pursuant to
November 7, 2016	EX-10.4	ACTIVECARE, INC. NON-QUALIFIED STOCK OPTION AGREEMENT Exhibit 10.4 ACTIVECARE, INC. NON-QUALIFIED STOCK OPTION AGREEMENT EMPLOYEE THIS NON-QUALIFIED STOCK OPTION AGREEMENT (the " Agreement") entered into as of the day of , by and between ActiveCare, Inc. (the " Company") and (the " Optionee"). WHEREAS, pursuant to the authority of the Board of Directors (the " Board"), the Company has granted the Optionee the right to purchase common stock, $0.00001
November 7, 2016	EX-10.1	ACTIVECARE, INC. 2016 EQUITY AND INCENTIVE PLAN Exhibit 10.1 ACTIVECARE, INC. 2016 EQUITY AND INCENTIVE PLAN SECTION 1. GENERAL PURPOSE OF THE PLAN: DEFINITIONS The name of the plan is the ACTIVECARE, INC. 2016 EQUITY AND INCENTIVE PLAN (the "Plan"). The purpose of the Plan is to encourage and enable the officers, employees, directors, Consultants and other key persons of ActiveCare, Inc., a Delaware corporation (including any successor entity,
November 7, 2016	EX-10.5	ACTIVECARE, INC. INCENTIVE STOCK OPTION AGREEMENT Exhibit 10.5 ACTIVECARE, INC. INCENTIVE STOCK OPTION AGREEMENT This Incentive Stock Option Agreement (" Agreement") is made and entered into as of the date set forth below, by and between ActiveCare, Inc., a Delaware corporation (the " Company"), and the employee of the Company named in Section 1(b). (" Optionee"): In consideration of the covenants herein set forth, the parties hereto agree as fol
September 24, 2016	EX-4.1	COMMON STOCK PURCHASE WARRANT DOCUMENT W-09192016 ACTIVECARE, INC. Exhibit 4.1 THIS WARRANT AND THE SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT OR APPLICABLE EXEMPTION OR SAFE HARBOR PROVISION. COMMON STOCK PURCHAS
September 24, 2016	EX-10.1	SECURITIES PURCHASE AGREEMENT DOCUMENT SPA-09192016 Exhibit 10.1 SECURITIES PURCHASE AGREEMENT DOCUMENT SPA-09192016 This Securities Purchase Agreement (this " Agreement") is dated as of September 19, 2016, between ActiveCare, Inc., a Delaware corporation (the " Issuer") and JMJ Financial (the " Investor") (referred to collectively herein as the " Parties"). WHEREAS, the Issuer filed an S-1 registration statement with the SEC on July 19, 2016 with
September 24, 2016	EX-10.4	CONDITIONALLY-EFFECTIVE WARRANT CANCELLATION AGREEMENT Exhibit 10.4 CONDITIONALLY-EFFECTIVE WARRANT CANCELLATION AGREEMENT THIS CONDITIONALLY-EFFECTIVE WARRANT CANCELLATION AGREEMENT (this " Agreement") is made as of September 9 , 2016, by and between the undersigned (the " Warrant Holders") and ActiveCare, Inc., a Delaware corporation (the " Company"). RECITALS A. The Company previously granted to the Warrant Holders (i) that certain warrant for 7,20
September 24, 2016	EX-10.3	FORBEARANCE UNDER LOAN AND SECURITY AGREEMENT Exhibit 10.3 FORBEARANCE UNDER LOAN AND SECURITY AGREEMENT This Forbearance under Loan and Security Agreement (this " Forbearance") is entered into as of September 9 , 2016 (the " Forbearance Effective Date"), by and between Partners for Growth IV, L.P., a Delaware limited partnership with its principal place of business at 1660 Tiburon Blvd., Suite D, Tiburon California 94920 (" PFG") and ActiveC
September 24, 2016	EX-10.2	PROMISSORY NOTE Exhibit 10.2 ACAR PROMISSORY NOTE FOR VALUE RECEIVED, ActiveCare, Inc., a Delaware corporation (the "Issuer" of this Security) with at least 110,000,000 common shares issued and outstanding, issues this Security and promises to pay to JMJ Financial, a Nevada sole proprietorship, or its Assignees (the "Investor") the Principal Sum along with the Interest Rate and any other fees according to the ter
September 24, 2016	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 19, 2016 ACTIVECARE, INC. (Exact name of registrant as specified in its charter) Delaware 000-53570 87-0578125 (State or other jurisdiction of incorporation) (Commission Fil
September 24, 2016	EX-10.4	CONDITIONALLY-EFFECTIVE WARRANT CANCELLATION AGREEMENT Exhibit 10.4 CONDITIONALLY-EFFECTIVE WARRANT CANCELLATION AGREEMENT THIS CONDITIONALLY-EFFECTIVE WARRANT CANCELLATION AGREEMENT (this " Agreement") is made as of September 9 , 2016, by and between the undersigned (the " Warrant Holders") and ActiveCare, Inc., a Delaware corporation (the " Company"). RECITALS A. The Company previously granted to the Warrant Holders (i) that certain warrant for 7,20
September 24, 2016	EX-4.1	COMMON STOCK PURCHASE WARRANT DOCUMENT W-09192016 ACTIVECARE, INC. Exhibit 4.1 THIS WARRANT AND THE SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT OR APPLICABLE EXEMPTION OR SAFE HARBOR PROVISION. COMMON STOCK PURCHAS
September 24, 2016	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 19, 2016 ACTIVECARE, INC. (Exact name of registrant as specified in its charter) Delaware 000-53570 87-0578125 (State or other jurisdiction of incorporation) (Commission Fil
September 24, 2016	EX-10.1	SECURITIES PURCHASE AGREEMENT DOCUMENT SPA-09192016 Exhibit 10.1 SECURITIES PURCHASE AGREEMENT DOCUMENT SPA-09192016 This Securities Purchase Agreement (this " Agreement") is dated as of September 19, 2016, between ActiveCare, Inc., a Delaware corporation (the " Issuer") and JMJ Financial (the " Investor") (referred to collectively herein as the " Parties"). WHEREAS, the Issuer filed an S-1 registration statement with the SEC on July 19, 2016 with
September 24, 2016	EX-10.3	FORBEARANCE UNDER LOAN AND SECURITY AGREEMENT Exhibit 10.3 FORBEARANCE UNDER LOAN AND SECURITY AGREEMENT This Forbearance under Loan and Security Agreement (this " Forbearance") is entered into as of September 9 , 2016 (the " Forbearance Effective Date"), by and between Partners for Growth IV, L.P., a Delaware limited partnership with its principal place of business at 1660 Tiburon Blvd., Suite D, Tiburon California 94920 (" PFG") and ActiveC
September 24, 2016	EX-10.2	PROMISSORY NOTE Exhibit 10.2 ACAR PROMISSORY NOTE FOR VALUE RECEIVED, ActiveCare, Inc., a Delaware corporation (the "Issuer" of this Security) with at least 110,000,000 common shares issued and outstanding, issues this Security and promises to pay to JMJ Financial, a Nevada sole proprietorship, or its Assignees (the "Investor") the Principal Sum along with the Interest Rate and any other fees according to the ter
September 13, 2016	DEF 14C	Activecare DEF 14C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: o Preliminary Information Statement o Confidential, for use of the Commission only (as permitted by Rule 14c-5(d)(2)) x Definitive Information Statement ACTIVECARE, INC. (Name of Registrant
September 1, 2016	PRE 14C	Activecare PRE 14C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: x Preliminary Information Statement o Confidential, for use of the Commission only (as permitted by Rule 14c-5(d)(2)) o Definitive Information Statement ACTIVECARE, INC. (Name of Registrant
August 18, 2016	10-Q	Activecare ACTIVECARE, INC. 10Q 2016-06-30 (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2016 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-53570 ACTIVECARE, INC. (Exact
August 18, 2016	10-Q	Activecare ACTIVECARE, INC. 10Q 2016-06-30 (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2016 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-53570 ACTIVECARE, INC. (Exact
August 15, 2016	NT 10-Q	Activecare ACTIVECARE 12B25 10Q 2016-06-30 UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Expires: August 31, 2018 Washington, D.
July 19, 2016	EX-3.12	CERTIFICATE OF DESIGNATION THE RELATIVE RIGHTS AND PREFERENCES THE SERIES E CONVERTIBLE PREFERRED STOCK ACTIVECARE, INC. Exhibit 3.12 CERTIFICATE OF DESIGNATION OF THE RELATIVE RIGHTS AND PREFERENCES OF THE SERIES E CONVERTIBLE PREFERRED STOCK OF ACTIVECARE, INC. The undersigned, the Chief Financial Officer of ActiveCare, Inc., a Delaware corporation (the “Corporation”), in accordance with the provisions of the Delaware General Corporation Law, does hereby certify that, pursuant to the authority conferred upon the B
July 19, 2016	S-1	As filed with the Securities and Exchange Commission on July 19, 2016 As filed with the Securities and Exchange Commission on July 19, 2016 Registration No.
July 19, 2016	EX-3.10	AMENDED AND RESTATED CERTIFICATE OF DESIGNATION OF THE RELATIVE RIGHTS AND PREFERENCES OF THE SERIES C CONVERTIBLE PREFERRED STOCK OF ACTIVECARE, INC. Exhibit 3.10 AMENDED AND RESTATED CERTIFICATE OF DESIGNATION OF THE RELATIVE RIGHTS AND PREFERENCES OF THE SERIES C CONVERTIBLE PREFERRED STOCK OF ACTIVECARE, INC. The undersigned, the Chief Financial Officer of ActiveCare, Inc., a Delaware corporation (the ?Corporation?), in accordance with the provisions of the Delaware General Corporation Law, does hereby certify that, pursuant to the authority
July 19, 2016	EX-3.13	EX-3.13 Exhibit 3.13
July 19, 2016	EX-3.11	AMENDED AND RESTATED CERTIFICATE OF DESIGNATION OF THE RELATIVE RIGHTS AND PREFERENCES OF THE SERIES D CONVERTIBLE PREFERRED STOCK OF ACTIVECARE, INC. Exhibit 3.11 AMENDED AND RESTATED CERTIFICATE OF DESIGNATION OF THE RELATIVE RIGHTS AND PREFERENCES OF THE SERIES D CONVERTIBLE PREFERRED STOCK OF ACTIVECARE, INC. The undersigned, the Chief Financial Officer and Secretary of ActiveCare, Inc., a Delaware corporation (the “Corporation”), in accordance with the provisions of the Delaware General Corporation Law, does hereby certify that, pursuant to
July 19, 2016	EX-3.5	STATE OF DELAWARE CERTIFICATE OF CORRECTION FILED TO CORRECT A CERTAIN ERROR IN THE CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION OF ACTIVECARE, INC. FILED IN THE OFFICE OF THE SECRETARY OF STATE OF DELAWARE ON MAY 8, 2013 Exhibit 3.5 STATE OF DELAWARE CERTIFICATE OF CORRECTION FILED TO CORRECT A CERTAIN ERROR IN THE CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION OF ACTIVECARE, INC. FILED IN THE OFFICE OF THE SECRETARY OF STATE OF DELAWARE ON MAY 8, 2013 ACTIVECARE, INC., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the ?Corporation?)
July 19, 2016	EX-3.6	EX-3.6 Exhibit 3.6
July 19, 2016	EX-3.15	EX-3.15 Exhibit 3.15
July 11, 2016	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 7, 2016 ActiveCare, Inc. (Exact name of registrant as specified in its charter) Utah (State or other jurisdiction of incorporation) 000-53570 87-0578125 (Commission file number) (IRS employer i
July 11, 2016	EX-99.1	CONSULTING AGREEMENT By and Between: ACTIVECARE, INC. a Delaware corporation (the " Company") JAMES DALTON (the " Consultant") ______________, 2016 TABLE OF CONTENTS Exhibit 99.1 CONSULTING AGREEMENT By and Between: ACTIVECARE, INC. a Delaware corporation (the " Company") and JAMES DALTON (the " Consultant") , 2016 TABLE OF CONTENTS Page 1 Engagement 1 (a) Services 1 (b) Performance of the Services. 1 (c) No Conflict of Interest 2 2 Independent Contractor Relationship 2 3 Compensation 3 (a) Consulting Fee 3 (b) Expenses 3 4 Term and Termination 3 (a) Term 3 (b
May 23, 2016	EX-10.14	AMENDED AND RESTATED CONSULTING AGREEMENT By and Between: ACTIVECARE, INC. a Delaware corporation (the " Company") ADP MANAGEMENT CORPORATION a Utah corporation (the " Consultant") ______________, 2016 TABLE OF CONTENTS Exhibit 10.14 AMENDED AND RESTATED CONSULTING AGREEMENT By and Between: ACTIVECARE, INC. a Delaware corporation (the " Company") and ADP MANAGEMENT CORPORATION a Utah corporation (the " Consultant") , 2016 TABLE OF CONTENTS Page 1 Engagement 1 (a) Services 1 (b) Performance of the Services. 1 (c) No Conflict of Interest 2 2 Independent Contractor Relationship 2 3 Compensation 3 (a) Consulting Fee
May 23, 2016	10-Q	Activecare FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2016 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-53570 ActiveCare
May 11, 2016	NT 10-Q	Activecare ACTIVECARE 12B25 10Q 2016-03-31 acar12b-25.htm UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Expires: August 31, 2018 Washington, D.C. 20549 Estimated average burden Hours per response 2.50 FORM 12b-25 SEC FILE NUMBER 0-53570 NOTIFICATION OF LATE FILING CUSIP NUMBER (Check One): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: March 31,
April 11, 2016	SC 13G	ACAR / Activecare Inc. / Tonaquint, Inc. - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. n/a )* ActiveCare, Inc. (Name of Issuer) Common Stock, $0.00001 par value (Title of Class of Securities) 005057203 (CUSIP Number) April 11, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the r
February 25, 2016	EX-10.7	PROMISSORY NOTE Exhibit 10.7 PROMISSORY NOTE U.S. $ 541,685.37 February 18, 2016 FOR VALUE RECEIVED, the undersigned, ActiveCare, Inc. ("Borrower") promises to pay ADP Management Corp. ("Lender") 1401 North 1075 West, Suite 240, Farmington, UT 84025 or at other place as Lender may designate in writing, the original principal sum of Five Hundred Forty One Thousand, Six Hundred Eight Five Dollars and Thirty Seven C
February 25, 2016	EX-10.1	[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] Exhibit 10.13 WARRANT THIS WARRANT ("WARRANT") TO PURCHASE SHARES IN THE CAPITAL OF ACTIVECARE, INC., A DELAWARE CORPORATION (THE "COMPANY") IS ISSUED ON THE ISSUE DATE PURSUANT TO THE TERMS OF THAT CERTAIN LOAN AND SECURITY AGREEMENT BETWEEN THE COMPANY AND PARTNERS FOR GROWTH IV, L.P. (THE "LOAN AGREEMENT"). THIS WARRANT IS SOLD IN A PRIVATE TRANSACTION, WITHOUT REGISTRATION UNDER THE SECURITIES
February 25, 2016	EX-10.6	Addendum #1 to the Settlement Agreement Between ActiveCare, Inc. and Bluestone Advisors Dated September 23, 2015 On this day of February 16, 2016, this Addendum#1 associated with the Settlement Agreement dated September 23, 2015 by and between Active Exhibit 10.6 Addendum #1 to the Settlement Agreement Between ActiveCare, Inc. and Bluestone Advisors Dated September 23, 2015 On this day of February 16, 2016, this Addendum#1 associated with the Settlement Agreement dated September 23, 2015 by and between ActiveCare, Inc. (Borrower) and Bluestone Advisors (Lender) is agreed to be altered in the following to points: 1) Lender agrees to subordinate
February 25, 2016	EX-10.11	10% CONVERTIBLE DEBENTURE DUE NOVEMBER 1, 2018 Exhibit 10.11 Original Issue Date: February , 2016 Original Conversion Price (subject to adjustment herein): $0.30 $ 10% CONVERTIBLE DEBENTURE DUE NOVEMBER 1, 2018 THIS 10% CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued 10% Convertible Debentures of ActiveCare, Inc., a Delaware corporation, (the "Company"), having its principal place of business at 1365 West Busines
February 25, 2016	EX-10.12	COMMON STOCK PURCHASE WARRANT ACTIVECARE, INC. Exhibit 10.12 EXHIBIT C COMMON STOCK PURCHASE WARRANT ACTIVECARE, INC. Warrant Shares: Initial Exercise Date: February 19, 2016 Holding Period Date: December 16, 2013 THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at
February 25, 2016	EX-10.4	MERCHANT AGREEMENT Exhibit 10.4 MERCHANT AGREEMENT Agreement dated February 11, 2016 between , Inc. ("" and/or "FUNDER") and the merchant listed below ("the Merchant"). Business Legal Name: ACTIVECARE, INC D/B/A: VOLU-SOL, REAL TIME HEALTH, GWIRE CORPORATION, ORBIT MEDICAL RESPONSE, RAPID MEDICAL RESPONSE, GREENWIRE Type of entity (check one) X Corporation LLC Limited Partnership Limited Liability Partnership Sole P
February 25, 2016	EX-10.8	SECURED CONVERTIBLE PROMISSORY NOTE Exhibit 10.8 THIS SECURED CONVERTIBLE PROMISSORY NOTE IS ISSUED IN EXCHANGE FOR (WITHOUT ANY ADDITIONAL CONSIDERATION) A CERTAIN PROMISSORY NOTE IN THE PRINCIPAL AMOUNT OF $243,081.70 ORIGINALLY ISSUED BY BORROWER (AS DEFINED BELOW) TO LENDER (AS DEFINED BELOW) AS OF NOVEMBER 25, 2014, BUT WHICH NOTE WAS SUBSEQUENTLY EXCHANGED FOR A NEW PROMISSORY NOTE ON JANUARY 13, 2015. HOWEVER, FOR ALL PURPOSE
February 25, 2016	EX-10.10	Addendum #1 to the Settlement Agreement Between ActiveCare, Inc. and Advance Technology Investors Dated May 20, 2015 Exhibit 10.10 Addendum #1 to the Settlement Agreement Between ActiveCare, Inc. and Advance Technology Investors Dated May 20, 2015 On this day of February 16, 2016, this Addendum#1 associated with the Promissory Note dated May 20, 2015 by and between ActiveCare, Inc. (Borrower) and Advance Technology Investors (Lender) is agreed to be altered in the following to points: 1) Lender agrees to subordi
February 25, 2016	EX-10.9	Purchase and Sale Agreement ("Agreement") Exhiibit 10.9 Purchase and Sale Agreement ("Agreement") 1. ASSIGNMENT. ("") hereby buys and ACTIVECARE, INC. D/B/A 4G BIOMETRICS AND/OR REAL TIME HEALTH ("Seller") hereby sells, transfers and assigns all of Seller's right, title and interest in and to those specific accounts receivable owing to Seller as set forth on the assignment forms provided by (the "Assignments") together with all rights of
February 25, 2016	EX-10.5	SETTLEMENT AGREEMENT Exhibit 10.5 SETTLEMENT AGREEMENT This Settlement Agreement ("Agreement") is made effective this 9th day of February, 2016 by and between ActiveCare, Inc., a Delaware corporation (the "Company"), and , an individual (the "Investor"). WHEREAS, the Company and Investor entered into an Account Receivable Purchase Agreement dated September 5, 2014 ("A/R Agreement") wherein Investor invested $; and WHE
February 25, 2016	EX-10.3	NOTICE OF CONVERSION (2015 Bridge Loan – Promissory Notes) Exhibit 10.3 NOTICE OF CONVERSION (2015 Bridge Loan – Promissory Notes) TO: ActiveCare, Inc. 1365 West Business Park Avenue Orem, Utah 84058 Attn: James Dalton, Chief Executive Officer 1. The undersigned noteholder ("Noteholder") is the holder of one or more Promissory Notes ("Notes") in the aggregate principal amount of Three Hundred Fifty Thousand Dollars ($350,000) issued by ActiveCare, Inc., a
February 24, 2016	EX-10.2	SECURITIES EXCHANGE AGREEMENT Exhibit 10.2 SECURITIES EXCHANGE AGREEMENT This Securities Exchange Agreement (this " Agreement") is dated as of February 19, 2016, between ActiveCare, Inc., a Delaware corporation (the " Company"), and each holder identified on the signature pages hereto (each, including its successors and assigns, a " Holder" and collectively, the " Holders"). WHEREAS, subject to the terms and conditions set for
February 24, 2016	EX-10.1	Loan and Security Agreement Exhibit 10.1 Partners for Growth Loan and Security Agreement Borrower: ActiveCare, Inc. a Delaware corporation Address: 1365 West Business Park Drive, Suite 100, Orem, UT 84058 Date: February 19, 2016 THIS LOAN AND SECURITY AGREEMENT (" Agreement") is entered into on the above date (the " Effective Date") between PARTNERS FOR GROWTH IV, L.P. (" PFG"), whose address is 1660 Tiburon Blvd., Suite D,
February 24, 2016	10-Q	Activecare ACTIVECARE, INC. 10Q 2015-12-31 (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: December 31, 2015 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-53570 ActiveC
February 16, 2016	NT 10-Q	Activecare ACTIVECARE 12B25 10Q 2015-12-31 acar12b-25.htm UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Expires: August 31, 2018 Washington, D.C. 20549 Estimated average burden Hours per response 2.50 FORM 12b-25 SEC FILE NUMBER 0-53570 NOTIFICATION OF LATE FILING CUSIP NUMBER (Check One): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: December 3
January 13, 2016	EX-10.6	SETTLEMENT AGREEMENT Exhibit 10.6 SETTLEMENT AGREEMENT This Settlement Agreement ("Agreement") executed this 23rd day of September, 2015 with an effective date as of the day of July, 2015 by and between the Bluestone Advisors, LLC ("Bluestone"), Blackhawk Properties, LLC ("Blackhawk"), Banyan Investment Company LLC ("Banyan"), The Mark and Nancy Peterson Foundation ("Foundation"), Tyumen Holdings, LLC ("Tyumen") and w
January 13, 2016	EX-10.9	SUBLEASE AGREEMENT Exhibit 10.9 SUBLEASE AGREEMENT This sublease made the 10th day of June, 2015, between ActiveCare, Inc hereinafter referred to as sublessee and Humaneyezed LLC, Domega Inc. and LandVoice Data, LLC hereinafter referred to as sublessor. WITNESSETH; that the sublessor hereby subleases to the sublessee, and the sublessee hereby hires and takes from the sublessor, the following premises; approximately
January 13, 2016	EX-10.5	CONSULTING AGREEMENT By and Between: ACTIVECARE, INC. a Delaware corporation (the "Company") ADP MANAGEMENT CORPORATION a Utah corporation (the "Consultant") September 23, 2015 TABLE OF CONTENTS Exhibit 10.5 CONSULTING AGREEMENT By and Between: ACTIVECARE, INC. a Delaware corporation (the "Company") and ADP MANAGEMENT CORPORATION a Utah corporation (the "Consultant") September 23, 2015 TABLE OF CONTENTS Page 1. ENGAGEMENT. (a) Services (b) Performance of the Services. (c) No Conflict of Interest 2. INDEPENDENT CONTRACTOR RELATIONSHIP 3. COMPENSATION (a) Consulting Fee (b) Expenses 4. TERM
January 13, 2016	EX-10.3	CONSULTING AGREEMENT By and Between: ACTIVECARE, INC. a Delaware corporation (the "Company") BLUESTONE ADVISORS, LLC a Utah limited liability company (the "Consultant") September 23, 2015 Exhibit 10.3 CONSULTING AGREEMENT By and Between: ACTIVECARE, INC. a Delaware corporation (the "Company") and BLUESTONE ADVISORS, LLC a Utah limited liability company (the "Consultant") September 23, 2015 Page 1 Engagement. 1 (a) Services 1 (b) Performance of the Services. 2 (c) No Conflict of Interest 2 2 Independent Contractor Relationship 3 3 Compensation 3 (a) Consulting Fee 3 (b) Bonuses. 3 (
January 13, 2016	EX-10.8	SETTLEMENT AGREEMENT Exhibit 10.8 SETTLEMENT AGREEMENT This Settlement Agreement ("Agreement") is made effective this 20th day of May, 2015 by and between ActiveCare, Inc., a Delaware corporation (the "Company"), and Advance Technology Investors, LLC ("ATI"). WHEREAS, the Company and ATI entered into that certain Distribution Agreement dated October 3, 2013 (the "Distribution Agreement") and attached hereto as Exhibit
January 13, 2016	10-K	ACAR / Activecare Inc. 10-K - Annual Report - ACTIVECARE, INC. 10K 2015-09-30 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2015 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0-53570 ActiveCare, Inc
January 13, 2016	EX-10.2	EXECUTIVE EMPLOYMENT AGREEMENT Exhibit 10.2 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (this "Agreement") executed this 23rd day of September, 2015 with an effective date as of the day of July 2015 (the "Effective Date"), by and between ACTIVECARE, INC., a Delaware corporation having its principal place of business in Salt Lake City, Utah (the "Company"), and JAMES DALTON, a resident of Utah (the "Execut
January 13, 2016	EX-10.7	PROMISSORY NOTE Exhibit 10.7 PROMISSORY NOTE U.S. $339,015.55 September 2, 2015 The undersigned, ActiveCare, Inc., a Delaware corporation ("Borrower"), promises to pay ADP Management Corporation, a Utah corporation ("Lender"), at 1401 North 1075 West, Suite 240, Farmington, Utah 84025 or at such other place as Lender may designate in writing, the original principal sum of $339,015.55 together with other amounts w
January 13, 2016	EX-10.3	INDEMNIFICATION AGREEMENT Exhibit 10.4 INDEMNIFICATION AGREEMENT THIS INDEMNIFICATION AGREEMENT (the "Agreement") is made and entered into this day of 2014, between ActiveCare, Inc., a Delaware corporation (the "Company"), and ("Indemnitee"). RECITALS A. Indemnitee, as a member of the Company's Board of Directors and/or an officer of the Company, performs valuable services for the Company. B. The Company and Indemnitee rec
December 24, 2015	NT 10-K	Activecare FORM 12B-25 UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Expires: August 31, 2018 Washington, D.
August 19, 2015	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2015 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-53570 ActiveCare,
August 14, 2015	NT 10-Q	Activecare FORM 12B-25 UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Expires: August 31, 2015 Washington, D.
May 29, 2015	8-K	Activecare ACTIVECARE, INC. 8K 2015-05-27 (Current Report/Significant Event) activecaare.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 27, 2015 ActiveCare, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-53570 (Commission File
May 15, 2015	EX-10.3	ADDENDUM AGREEMENT #3 Exhibit 10.3 ADDENDUM AGREEMENT #3 This Addendum Agreement #3 (?Addendum?) is entered into effective January 5, 2015, as an addendum and modification to the Asset Purchase Agreement dated effective as of September 1, 2012 (?Asset Purchase Agreement?), Addendum Agreement dated March 31, 2013, and Addendum Agreement #2 dated June 6, 2014 all of which were entered into by and among Gwire Corporation,
May 15, 2015	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2015 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-53570 ActiveCare
April 23, 2015	8-K	Activecare ACTIVECARE, INC. 8K 2015-04-18 (Current Report/Significant Event) activecare.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 18, 2015 ActiveCare, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-53570 (Commission Fil
March 6, 2015	8-K	Activecare FORM 8-K (Current Report/Significant Event) acar8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 1, 2015 ActiveCare, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-53570 (Commission File Num
February 23, 2015	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: December 31, 2014 or o? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-53570 Active
February 12, 2015	NT 10-Q	ACAR / Activecare Inc. NT 10-Q - - FORM 12B-25 UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Expires: August 31, 2015 Washington, D.
January 13, 2015	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2014 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0-53570 ActiveCare, Inc
January 13, 2015	EX-10.18	ACTIVECARE, INC. AMENDED AND RESTATED CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS SERIES F VARIABLE RATE CONVERTIBLE PREFERRED STOCK OF ACTIVECARE, INC. PURSUANT TO SECTION 151 OF THE DELAWARE GENERAL CORPORATION LAW Exhibit 10.18 ACTIVECARE, INC. AMENDED AND RESTATED CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES F VARIABLE RATE CONVERTIBLE PREFERRED STOCK OF ACTIVECARE, INC. PURSUANT TO SECTION 151 OF THE DELAWARE GENERAL CORPORATION LAW The undersigned, Marc Bratsman, does hereby certify that: 1. He is the CFO and Secretary, of ActiveCare, Inc., a Delaware corporation (the ?Corp
January 13, 2015	EX-10.19	DIVIDEND AGREEMENT Exhibit 10.19 DIVIDEND AGREEMENT THIS DIVIDEND AGREEMENT (this ?Agreement?), dated as of August 15th, 2014, and effective from the date of the Purchase Agreement (as defined below), is entered into among ActiveCare, Inc., a Delaware corporation (the ?Company?), and each of Hillair Capital Investments L.P., Alpha Capital Anstalt and Osher Capital Partners LLC (the ?Primary Holders?). Capitalized te
January 5, 2015	EX-10.1	FORM OF AGREEMENT FOR PURCHASE AND SALE OF MONITORING ACCOUNTS Exhibit 10.1 FORM OF AGREEMENT FOR PURCHASE AND SALE OF MONITORING ACCOUNTS THIS AGREEMENT is made on the day of , by and between [INSERT BUYER NAME AND ADDRESS], hereinafter referred to as “BUYER” and [INSERT SELLER NAME AND ADDRESS] collectively referred to as the “SELLER”. WITNESSETH: The BUYER and the SELLER, by affixing to this Agreement their signature agree as follows: Section 1. Property.
January 5, 2015	8-K	Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 31, 2014 ActiveCare, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-53570 (Commission File Number) 87
December 29, 2014	NT 10-K	ACAR / Activecare Inc. NT 10-K - - FORM 12B-25 UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Expires: August 31, 2015 Washington, D.
November 12, 2014	10-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2013 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0-53570 ActiveCare, I
November 12, 2014	10-Q/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2014 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number:
November 12, 2014	10-Q/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: December 31, 2013 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe
November 12, 2014	10-Q/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2014 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-53
October 6, 2014	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 30, 2014 ActiveCare, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-53570 (Commission File Number) 8
October 2, 2014	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 30, 2014 ActiveCare, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-53570 (Commission File Number) 8
September 24, 2014	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 24, 2014 ActiveCare, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-53570 (Commission File Number) 8
August 22, 2014	EX-99.2	ActiveCare Provides Revenue Projections of Approximately $11 Million For Next 12 Months Exhibit 99.2 ActiveCare Provides Revenue Projections of Approximately $11 Million For Next 12 Months Orem, Utah, August 25, 2014—ActiveCare Inc. (ACAR), a leader in diabetes monitoring and wellness services for self-insured employers nationwide, today provided a published report of revenue projections and a strategic business plan that details ActiveCare’s vision for the next twelve months. “We ar
August 22, 2014	EX-99.1	EX-99.1 EX-99.1 2 exhibit99-1.htm CORPORATE PRESENTATION Exhibit 99.1
August 22, 2014	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 22, 2014 ActiveCare, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-53570 (Commission File Number) 87-0
August 19, 2014	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2014 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-53570 ActiveCare,
August 14, 2014	NT 10-Q	ACAR / Activecare Inc. NT 10-Q - - FORM 12B-25 UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Expires: August 31, 2015 Washington, D.
July 18, 2014	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 16, 2014 ActiveCare, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-53570 (Commission File Number) 87-057
July 9, 2014	SC 13D	ACAR / Activecare Inc. / ADVANCE TECHNOLOGY INVESTORS, LLC - SCHEDULE 13D Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13D Under the Securities Exchange Act of 1934 ActiveCare, Inc. (Name of Issuer) Common Stock, $0.00001 par value (Title of Class of Securities) 005057203 (CUSIP Number) Advance Technology Investors, LLC Attn: Bernard Zicherman 154 Rock Hill Road Spring Valley, New York 10977 (917) 968-3558 (Name, Address and Telephone Number of Per
May 30, 2014	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 30, 2014 ActiveCare, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-53570 (Commission File Number) 87-0578
May 21, 2014	DEF 14C	- ACTIVECARE, INC. DEF 14C 2014-05-21 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ¨ Preliminary Information Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) þ Definitive Information Statement ActiveCare, Inc. (Name of Registrant
May 19, 2014	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2014 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-53570 ActiveCare
May 14, 2014	NT 10-Q	- FORM 12B-25 UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Expires: August 31, 2015 Washington, D.
May 5, 2014	8-K/A	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 27, 2014 ActiveCare, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-53570 (Commissio
May 2, 2014	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - ACTIVECARE, INC. FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 27, 2014 ActiveCare, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-53570 (Commission File Number) 87-05
April 30, 2014	PRE 14C	- ACTIVECARE, INC. PRE 14C 2014-04-29 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: þ Preliminary Information Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ¨ Definitive Information Statement ActiveCare, Inc. (Name of Registrant
February 20, 2014	EX-10.8	AMENDMENT AGREEMENT Exhibit 10.8 AMENDMENT AGREEMENT THIS AMENDMENT AGREEMENT (this “Agreement”), dated as of February , 2014 and is effective December 16, 2013 is entered into by and between ActiveCare, Inc., a Delaware corporation (the “Company”) and each of the purchasers identified on the signature pages hereof (the “Purchasers”). Capitalized terms used herein, but not otherwise defined, shall have the meanings a
February 20, 2014	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q activecare.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: December 31, 2013 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number:
February 20, 2014	EX-10.7	February 10, 2014 Exhibit 10.7 February 10, 2014 Mr. David Derrick Chief Executive Officer Chairman of the Board ActiveCare, Inc. 1365 West Business Park Drive Orem, UT 84058 Dear David, After numerous discussions and serious reflection on my part it is with regret that I submit my resignation as a member of the Board of Directors ActiveCare, Inc. I have had no disagreements with you, management or the Company, but
February 19, 2014	EX-10.7	February 10, 2014 Exhibit 10.7 February 10, 2014 Mr. David Derrick Chief Executive Officer Chairman of the Board ActiveCare, Inc. 1365 West Business Park Drive Orem, UT 84058 Dear David, After numerous discussions and serious reflection on my part it is with regret that I submit my resignation as a member of the Board of Directors ActiveCare, Inc. I have had no disagreements with you, management or the Company, but
February 19, 2014	EX-10.8	AMENDMENT AGREEMENT Exhibit 10.8 AMENDMENT AGREEMENT THIS AMENDMENT AGREEMENT (this “Agreement”), dated as of February , 2014 and is effective December 16, 2013 is entered into by and between ActiveCare, Inc., a Delaware corporation (the “Company”) and each of the purchasers identified on the signature pages hereof (the “Purchasers”). Capitalized terms used herein, but not otherwise defined, shall have the meanings a
February 19, 2014	18-K	- ACTIVECARE, INC. 10Q 2013-12-31 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: December 31, 2013 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-53570 ActiveC
February 14, 2014	NT 10-Q	- FORM 12B-25 UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Expires: August 31, 2015 Washington, D.
January 14, 2014	EX-10.3	SECURITY AGREEMENT Exhibit 10.3 SECURITY AGREEMENT This SECURITY AGREEMENT (this “Agreement”) is dated as of November , 2012, and is entered into by and between GWire Corporation, a Utah corporation (the “Company”); Rapid Medical Response, LLC, a Utah limited liability company (“Rapid”); Orbit Medical Response, LLC, a Utah limited liability company (“Response”); and Green Wire, LLC, a Utah limited liability company
January 14, 2014	EX-10.4	GUARANTY AGREEMENT Exhibit 10.4 GUARANTY AGREEMENT This GUARANTY AGREEMENT (the ?Guaranty?) is made as of November , 2012, by ActiveCare, Inc. a Delaware corporation (?Guarantor?), for the benefit of Rapid Medical Response, LLC, a Utah limited liability company (?Rapid?), Orbit Medical Response, LLC, a Utah limited liability company (?Orbit?), and Green Wire, LLC, a Utah limited liability company (?Green Wire,? with
January 14, 2014	EX-10.6	EMPLOYMENT AGREEMENT By and between: GWire CORPORATION a Utah corporation DAVID LEE Exhibit 10.6 EMPLOYMENT AGREEMENT By and between: GWire CORPORATION a Utah corporation and DAVID LEE TABLE OF CONTENTS Page 1 Position and Responsibilities. 1 (a) Position 1 (b) Other Activities 1 (c) No Conflict 1 2 Compensation and Benefits. 1 (a) Compensation 1 (b) Equity Incentive Share Bonus 1 (c) Stock Options.. 2 (d) Vacation 2 (e) Benefits 2 (f) Expenses 2 3 Term 2 4 Termination of Employm
January 14, 2014	EX-10.1	ASSET PURCHASE AGREEMENT by and among GWIRE CORPORATION as the Purchaser, RAPID MEDICAL RESPONSE, LLC, ORBIT MEDICAL RESPONSE GREEN WIRE, LLC as the Sellers Dated Effective as of September 1, 2012 ASSET PURCHASE AGREEMENT Exhibit 10.1 ASSET PURCHASE AGREEMENT by and among GWIRE CORPORATION as the Purchaser, RAPID MEDICAL RESPONSE, LLC, ORBIT MEDICAL RESPONSE and GREEN WIRE, LLC as the Sellers Dated Effective as of September 1, 2012 ASSET PURCHASE AGREEMENT THIS ASSET PURCHASE AGREEMENT (this ?Agreement?), dated effective as of September 1, 2012, is made and entered into by and among GWire Corporation, a Utah corpor
January 14, 2014	EX-10.5	EMPLOYMENT AGREEMENT By and between: GWIRE CORPORATION a Utah corporation ANDREW BALL November 1, 2012 Exhibit 10.5 EMPLOYMENT AGREEMENT By and between: GWIRE CORPORATION a Utah corporation and ANDREW BALL November 1, 2012 TABLE OF CONTENTS Page 1 Position and Responsibilities. 1 (a) Position 1 (b) Other Activities 1 (c) No Conflict 1 2 Compensation and Benefits. 1 (a) Compensation 1 (b) Equity Incentive Share Bonus 1 (c) Stock Options.. 2 (d) Vacation 2 (e) Benefits 2 (f) Expenses 2 3 Term 2 4 Ter
January 14, 2014	EX-10.7	VOTING AGREEMENT AND IRREVOCABLE PROXY Exhibit 10.7 VOTING AGREEMENT AND IRREVOCABLE PROXY THIS VOTING AGREEMENT AND IRREVOCABLE PROXY (this ?Agreement?) is effective as of September 1, 2012, by and among GWire Corporation, a Utah corporation (the ?Corporation?), and each of Andrew Ball (?Ball?), David Lee (?Lee?) and ActiveCare, Inc., a Delaware corporation (?ActiveCare? and, with each of Ball and Lee, a ?Shareholder?. WHEREAS, Ball,
January 14, 2014	EX-10.2	SECURED PROMISSORY NOTE Exhibit 10.2 SECURED PROMISSORY NOTE $1,713,000.00 November , 2012 THIS SECURED PROMISSORY NOTE (this ?Note?) is made by GWIRE CORPORATION, a Utah corporation (?Maker?), having an address of 5095 West 2100 South, Salt Lake City, Utah 84120, to and in favor of Green Wire, LLC, a Utah limited liability company (?Payee? or ?Holder?), having an address at 4424 South 700 East, Suite 200, Salt Lake City
January 14, 2014	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2013 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0-53570 ActiveCare, Inc
December 27, 2013	8-K	Unregistered Sales of Equity Securities, Financial Statements and Exhibits - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 20, 2013 ActiveCare, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-53570 (Commission File Number) 87
December 27, 2013	EX-10.3	COMMON STOCK PURCHASE WARRANT ACTIVECARE, INC. Exhibit 10.3 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGIST
December 27, 2013	NT 10-K	- FORM 12B-25 UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Expires: August 31, 2015 Washington, D.
December 27, 2013	EX-10.2	ACTIVECARE, INC. CONVERSION NOTICE SHARES OF SERIES C OR SERIES D CONVERTIBLE PREFERRED STOCK THE CONVERSION RIGHTS WILL EXPIRE AT 5:00 P.M., NEW YORK CITY TIME, ON DECEMBER 6, 2013 (THE “EXPIRATION DATE”), UNLESS EXTENDED. ACTIVECARE, INC. Exhibit 10.2 ACTIVECARE, INC. CONVERSION NOTICE SHARES OF SERIES C OR SERIES D CONVERTIBLE PREFERRED STOCK THE CONVERSION RIGHTS WILL EXPIRE AT 5:00 P.M., NEW YORK CITY TIME, ON DECEMBER 6, 2013 (THE “EXPIRATION DATE”), UNLESS EXTENDED. ACTIVECARE, INC. By Regular Mail or Overnight Courier: ACTIVECARE, INC. By Facsimile Or e-mail: (866) 226-2595 or [email protected] 1365 West Business Park
December 27, 2013	EX-10.1	LOAN CONVERSION AGREEMENT Exhibit 10.1 LOAN CONVERSION AGREEMENT THIS LOAN CONVERSION AGREEMENT (this “Agreement”) is executed on (the “Effective Date”), by and between (“Lender”) and ActiveCare, Inc., a Delaware corporation (“Company”). RECITALS A. Company executed and delivered to Lender, as lender and holder, that certain Agreements, dated as of , in the original principal amount of , as amended the same may have been s
December 18, 2013	EX-10.2	COMMON STOCK PURCHASE WARRANT ACTIVECARE, INC. Warrant Shares: _______ Initial Exercise Date: December 16, 2013 Exhibit 10.2 EXHIBIT C NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECT
December 18, 2013	8-K	Unregistered Sales of Equity Securities, Financial Statements and Exhibits - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 16, 2013 ActiveCare, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-53570 (Commission File Number) 87
December 18, 2013	EX-99	ActiveCare Announces Exhibit 99 ActiveCare Announces 12/17/2013 Orem, Utah. ActiveCare, Inc. (OTCQB: ACAR) (www.activecare.com), a leader in diabetes management and wellness services, announced today it completed the sale of $3,120,000 in 8% Original Issue Discount Senior Convertible Series F Preferred in a private placement. Under the terms of the securities purchase agreement with Hillair Capital Investments L.P. an
December 18, 2013	EX-3.1	ACTIVECARE, INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS SERIES F VARIABLE RATE CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE DELAWARE GENERAL CORPORATION LAW Exhibit 3.1 EXHIBIT A ACTIVECARE, INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES F VARIABLE RATE CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE DELAWARE GENERAL CORPORATION LAW The undersigned, Michael Acton, does hereby certify that: 1. He is the CFO and Secretary, of ActiveCare, Inc., a Delaware corporation (the “Corporation”). 2. The Corporation is
December 18, 2013	EX-10.3	EXCHANGE AGREEMENT Exhibit 10.3 EXCHANGE AGREEMENT xxThis Exchange Agreement (this “Agreement”) is dated as of December 16, 2013, between ActiveCare, Inc., a Delaware corporation (the “Company”), and each acquirer identified on the signature pages hereto (each, including its successors and assigns, a “Acquirer” and collectively, the “Acquirers”). WHEREAS, subject to the terms and conditions set forth in this Agreeme
December 18, 2013	EX-10.1	SECURITIES PURCHASE AGREEMENT Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of December 16, 2013, between ActiveCare, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”). WHEREAS, subject to the terms and conditions se
September 4, 2013	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 25, 2013 ActiveCare, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-53570 (Commission File Number) 87-0
September 4, 2013	EX-99	ActiveCare Strengthens Balance Sheet with Closing of Equity Investment and Debt Conversion Exhibit 99 News Release ActiveCare Strengthens Balance Sheet with Closing of Equity Investment and Debt Conversion Orem, Utah — September 4, 2013 — ActiveCare, Inc.
August 27, 2013	EX-10.15	SECURITY AGREEMENT Exhibit 10.15 SECURITY AGREEMENT This SECURITY AGREEMENT, dated as of August 2, 2013 (this “Agreement”), is among ActiveCare Inc., a Delaware corporation (the “Company”), each Subsidiary of the Company which shall become a party to this Agreement by execution and delivery of the form annexed hereto as Annex A and the Subsidiary Guaranty annexed thereto (each such Subsidiary, the “Guarantor” and to
August 27, 2013	EX-10.13	SUBSCRIPTION AGREEMENT Exhibit 10.13 SUBSCRIPTION AGREEMENT THIS SUBSCRIPTION AGREEMENT (this “Agreement”), is dated as of August 2, 2013, by and between ActiveCare Inc., a Delaware corporation (the “Company”), and the subscribers identified on Schedule 1 hereto, which may be amended from time to time prior to Closing (the “Subscribers”). WHEREAS, the Company and the Subscribers are executing and delivering this Agreeme
August 27, 2013	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2013 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-53570 ActiveCare,
August 27, 2013	EX-10.14	SECURED CONVERTIBLE PROMISSORY NOTE Exhibit 10.14 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR
August 15, 2013	NT 10-Q	- FORM 12B-25 UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Expires: August 31, 2015 Washington, D.
July 17, 2013	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits - ACTIVECARE, INC. FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 15, 2013 ActiveCare, Inc. (Exact name of registrant as specified in its charter) Delaware 000-53570 87-0578125 (State or other jurisdiction of incorporation) (Commission File Num
July 17, 2013	EX-99	ActiveCare Announces Closing of $2.235 Million Capital Investment and $1.3 Million Debt Conversion Exhibit 99 News Release ActiveCare Announces Closing of $2.235 Million Capital Investment and $1.3 Million Debt Conversion Orem, Utah — July 17, 2013 — ActiveCare, Inc. (OTC.BB:ACAR), the service leader in disease and diabetes management, today announced the closing of a capital investment and debt conversion by its Chairman and Chief Executive Officer, David Derrick. Mr. Derrick has made cash adv
July 10, 2013	EX-99.1	EX-99.1 Exhibit 99.1
July 10, 2013	8-K	Regulation FD Disclosure, Financial Statements and Exhibits - ACTIVECARE, INC. FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 10, 2013 ACTIVECARE, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-53570 (Commission File No.) 87-057812
June 25, 2013	8-K	Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 13, 2013 ACTIVECARE, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-53570 (Commission File No.) 87-057812
June 25, 2013	EX-10.1	ASSET PURCHASE AGREEMENT Exhibit 10.1 ASSET PURCHASE AGREEMENT This ASSET PURCHASE AGREEMENT (“Agreement”) dated as of June 13, 2013 (the “Effective Date”) is between ACTIVECARE, INC., a Delaware corporation with its principal place of business at 1365 West Business Park Dr., Orem, Utah (“Seller”), and THE HORROCKS COMPANY, LLC, a Utah limited liability company (“Buyer”). Seller or Buyer may also be referred to in this Ag
May 20, 2013	EX-99.1	ACTIVECARE ANNOUNCES TEN-FOR-ONE REVERSE STOCK SPLIT Exhibit 99.1 ACTIVECARE ANNOUNCES TEN-FOR-ONE REVERSE STOCK SPLIT Salt Lake City, Utah — May 16, 2013 — ActiveCare, Inc. (OTC.BB:ACARD), the service leader in disease and diabetes management today announced a reverse stock split of its shares of common stock at a ratio of 10-for-1 for stockholders of record May 16, 2013. The stock split is effective today and the shares will trade on a post-split
May 20, 2013	EX-3.1	CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION ACTIVECARE, INC. Exhibit 3.1 CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION OF ACTIVECARE, INC. Pursuant to and in accordance with Section 242 of the General Corporation Law of the State of Delaware, as amended (the “DGCL”), the undersigned, ActiveCare, Inc. (the “Corporation”) hereby declares and certifies as follows: 1. The name of the Corporation is ActiveCare, Inc. 2. The Certificate of Incorpora
May 20, 2013	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Material Modification to Rights of Security Holders, Financial Statements and Exhibits - ACTIVECARE, INC. FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 [Missing Graphic Reference] FORM 8-K [Missing Graphic Reference] CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 16, 2013 ACTIVECARE, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of i
May 15, 2013	EX-10.12	EX-10.12 pdf reference
May 15, 2013	EX-10.10	EX-10.10 pdf reference
May 15, 2013	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2013 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-53570 ActiveCare
May 15, 2013	EX-10.12	EX-10.12
May 15, 2013	EX-10.11	EX-10.11 pdf reference
May 15, 2013	EX-10.10	EX-10.10
May 15, 2013	EX-10.11	EX-10.11
April 2, 2013	8-K	Submission of Matters to a Vote of Security Holders - ACTIVECARE, INC. FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 25, 2013 ActiveCare, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-53570 (Commission File Number) 87-05
February 21, 2013	SC 13G/A	ACAR / Activecare Inc. / GEMINI MASTER FUND LTD - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to Rules 13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to Rule 13d-2 (AMENDMENT NO. 1)* ActiveCare, Inc. (Name of Issuer) Common Stock, $0.00001 par value (Title of Class of Securities) 005057104 (CUSIP Number) December 31, 2012 (
February 19, 2013	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: December 31, 2012 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-53570 ActiveC
February 15, 2013	DEF 14A	- ACTIVECARE, INC. DEFINITIVE SCHEDULE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant þ Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of
February 14, 2013	NT 10-Q	- ACTIVECARE, INC. FORM 12B-25 UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Expires: May 31, 2012 Washington, D.
February 4, 2013	PRE 14A	- ACTIVECARE, INC. PRELIMINARY SCHEDULE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant þ Filed by a Party other than the Registrant o Check the appropriate box: þ Preliminary Proxy Statement o Confidential, for Use of
January 25, 2013	10-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2012 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0-5
January 15, 2013	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2012 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0-53570 ActiveCare, Inc
January 15, 2013	8-K/A	Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets - ACTIVECARE, INC. FORM 8-KA NOVEMBER 16, 2012 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 16, 2012 ActiveCare, Inc. (Exact name of registrant as specified in its charter) Delaware 000-53570 87-0578125 (State or other jurisdiction of incorporation) (Commission Fi
January 15, 2013	EX-99.1	Table of Contents Exhibit 99.1 Table of Contents Page Report of Independent Registered Public Accounting Firm 3 Combined Balance Sheets as of December 31, 2011 and 2010 4 Combined Statements of Operations for the Years Ended December 31, 2011 and 2010 5 Combined Statements of Equity for the Years Ended December 31, 2011 and 2010 6 Combined Statements of Cash Flows for the Years Ended December 31, 2011 and 2010 7 No
December 31, 2012	NT 10-K	- ACTIVECARE, INC. FORM 12B-25 UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Expires: August 31, 2015 Washington, D.
November 26, 2012	EX-99.1	Table of Contents 4G Biometrics, LLC Financial Statements As of September 30, 2011 and 2010 and For the Years Then Ended Together with Report of Independent Registered Public Accounting Firm Table of Contents Page Report of Independent Registered Public Accounting Firm 3 Balance Sheets as of September 30, 2011 and 2010 4 Statements of Operations for the Years Ended September 30, 2011 and 2010 5 Statements of Member
November 26, 2012	8-K/A	Financial Statements and Exhibits - ACTIVECARE, INC. 8K 2012-11-26 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 12, 2012 ActiveCare, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-53570 (Commission File Number) 87-0
November 19, 2012	8-K	Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets - ACTIVECARE, INC. FORM 8-K NOVEMBER 16, 2012 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 16, 2012 ActiveCare, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-53570 (Commission File Number) 87

ACAR / Activecare Inc. - SEC-arkiveringar, Årsredovisning, Fullmaktsutlåtande

Grundläggande statistik

SEC Filings

SEC Filings (Chronological Order)